Regression and non-progression of coronary artery disease with exercise

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 3, Issue 2, 1996, Pages 176-182

  Schuler, Gerhard ^a   Hambrecht, Rainer ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Leisure time physical activity; Myocardial ischaemia; Regression of coronary artery disease; Training

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; COLESTIPOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; NICOTINIC ACID;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE; FITNESS; HEART ARRHYTHMIA; HEART MUSCLE PERFUSION; HUMAN; LEISURE; LOW FAT DIET; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STRESS; WORK CAPACITY;

CORONARY DISEASE; DISEASE PROGRESSION; EXERCISE; HUMANS; LIPIDS; OXYGEN CONSUMPTION; STRESS;

EID: 0029792090     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182679600300208     Document Type: Article

References (36)

1. Blair SN Kohl HW Paffenbarger RS Clarke DG Cooper KH Gibbons LW etal: Physical fitness and all cause mortality. A prospective study of healthy men and women JAMA 1989, 262: 2395-2398.
2. Brensike JF Levy RI Kelsey SF Passamani ER Richardson JM Loh IK etal: Effects of therapy with cholestyramine on progression of coronary atherosclerosis. Results of the NHLBI type II coronary intervention study Circulation 1984, 69: 313-324.
3. Nikkilä EA Viikinkoski P Valle M Frick HM: Prevention of progression of coronary atherosclerosis by treatment of hyperlipidemia: A seven year prospective angiographic study BMJ 1984, 289: 220-223.
4. Blankenhom DH Nessim SA Johnson RL Sanmarco ME Azen SP Cashin-Hemphill L: Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass-grafts JAMA 1987, 257: 3233-3240.
5. Brown G Albers JJ Fisher LD Schaefer SM Lin JT Kaplan C etal: Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B N Engl J Med 1990, 323: 1289-1298. Patientswith high levels of apolipoprotein B(125 mg/dl) were treated with lipidlowering drugs (lovastatin, colestipol, niacin) for 2frac1s2 years. There was significant regression of coronary stenoses in both treatment groups, and reduction of mortality due to coronary heart disease.
6. Blankenhorn DH Azen SP Crawford DW Nessim SA Sanmarco ME Selzer RH etal: Effects of colestipol-niacin therapy on human femoral atherosclerosis Circulation 1991, 83: 438-447.
7. Buchwald H Varco RL Matts JP Long JM Fitch LL Campbell GS, And the POSCH Group: Effect of partial ileal bypass surgery on mortality and morbidity from coronary artery disease in patients with hypercholesterolemia N Engl J Med 1990, 323: 946-955. In421 patients, cholesterol lowering was achieved by partial ileal bypass surgery; the mean follow-up period was 9.7 years. Coronary angiography showed significantly less disease progression in the treatment group compared with the control group, but overall mortality and mortality due to coronary artery disease were not significantly reduced.
8. Kane JP Malloy MJ Ports TA Phillips NR Diehl JC Havel RJ: Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens JAMA 1990, 264: 3007-3012.
9. Blankenhorn DH Azen SP Kramsch DM Mack WJ Cashin-Hemphill L Hodis HN etal: Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS) Ann Intern Med 1993, 119: 969-976.
10. Waters D Higginson L Gladstone P Kimball B Le May M Boccuzzi SJ etal: Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: The Canadian Coronary Atherosclerosis Intervention Trial Circulation 1994, 89: 959-968.
11. Watts GF Lewis B Brunt JNH: Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas’ Atherosclerosis Regression Study (STARS) Lancet 1992, 339: 563-569. Patientswere treated with low-fat diet alone, or diet plus cholestyramine. Significant improvement of minimal stenosis diameter was noted in both treatment groups, and the frequency of cardiovascular events decreased compared with the control group.
12. Sacks FM Pasternak RC Gibson CM Rosner B Stone PH: Effects on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients Lancet 1994, 344: 1182-1186.
13. Investigators MAAS: Effect of simvastatin on coronary atheroma: The Multicenter Anti-Atheroma Study (MAAS) Lancet 1994, 344: 633-638.
14. Ornish D Brown SE Scherwitz LW Billings JH Armstrong WT Ports TA etal: Can lifestyle changes reverse coronary heart disease? Lancet 1990, 336: 129-133.
15. Schuler G Hambrecht R Schlierf G Niebauer J Hauer K Neumann J etal: Regular physical exercise and low fat diet: Effects on progression of coronary artery disease Circulation 1992, 86: 1-11.
16. Haskell WL Alderman EL Fair JM: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project (SCRIP) Circulation 1994, 89: 975-990. Three-hundred patients were randomized to multiple risk factor reduction or usual care. Treatment consisted of low-fat diet, regular exercise, weight loss, smoking cessation and lipid-lowering medication. Both groups showed progression of coronary artery disease, but the rate of narrowing was 47% less in the treatment group compared with the control group. There were three deaths in both groups; the number of hospitalizations due to cardiac events was 25 in the treatment group compared with 44 in the usual care group (P 0.05).
17. Kramsch DM Aspen AJ Abramowitz BM Kreimendahl T Hood WB: Reduction of coronary atherosclerosis by moderate conditioning exercise in monkeys on atherogenic diet N Engl J Med 1981, 305: 1483-1487.
18. Armstrong ML Warner ED Connor WE: Regression of coronary atheromatosis in rhesus monkeys Circ Res 1970, 27: 59-67.
19. Reiber JH Serruys PW Kooijman CJ Wijns W Slager CJ Gerbrands JJ etal: Assessment of short-, medium-, and long term variations in arterial dimensions from computer assisted quantification of coronary cineangiograms Circulation 1985, 71: 280-288. Thetechnical and biological aspects of quantitative coronary angiography are discussed in this study. The variability in obstruction diameter ranged from 0.22 mm (medium-term) to 0.36 mm in long-term studies.
20. Gould KL: Quantification of coronary artery stenosis in vivo Circ Res 1985, 57: 341-353.
21. Brown BG Bolson E Frimer M Dodge HT: Quantitative coronary angiography, estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation Circulation 1977, 55: 329-337.
22. Detry JM Rousseau M Vandenbrouke G Kusumi F Brasseur LA Bruce R: Increased arteriovenous oxygen difference after physical training in coronary artery disease Circulation 1971, 44: 109-115.
23. Blomquist CG Saltin B: Cardiovascular adaptations to physical training Am Rev Physiol 1983, 45: 169-175.
24. Froelicher V Jensen D Genter F Sullivan M McKirnan MD Witztum K etal: A randomized trial of exercise training in patients with coronary artery disease JAMA 1984, 252: 1291-1297.
25. Niebauer J Hambrecht R Schlierf G Marburger C Kälberer B Kübler W etal: Five years of physical exercise and low fat diet: Effects on progression of coronary artery disease J Cardiopul Rehabil 1994, 15: 47-64.
26. Hambrecht R Niebauer J Marburger C Grunze M Kälberer B Hauer K etal: Various intensities of leisure time physical activity in patients with coronary artery disease: Effects of cardiorespiratory fitness and progression of coronary atherosclerotic lesions J Am Coll Cardiol 1993, 22: 468-477. Acorrelation between leisure time physical activity and progression of coronary artery disease was detected in this study. Regression of coronary lesions is observed only in patients willing to spend more than 2200 kcal/week.
27. Taylor HL Jacobs DR Schucker B Knudsen J Leon AS DeBacker G: A questionnaire for the assessment of leisure time physical activities J Chron Dis 1978, 31: 741-755.
28. Hambrecht R Fiehn E Niebauer J Kälberer K Hauer K Offner B etal: Physical training in patients with stable congestive heart failure: Effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995 (in press).
29. Ehsani AA Heath GW Hagberg JM Sobel BE Holloszy JO: Effects of 12 months of intensive exercise training on ischemic ST-segment depression in patients with coronary artery disease Circulation 1981, 64: 1116-1121.
30. Schuler G Hambrecht R Schlierf G Grunze M Methfessel S Hauer K etal: Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet J Am Coll Cardiol 1992, 19: 34-42.
31. Ferguson RJ Petitclerc R Choquette G Chaniotis L Gauthier P Huot R etal: Effects of physical training on treadmill exercise capacity, collateral circulation and progression of coronary disease Am J Cardiol 1974, 34: 764-769.
32. Yates C Bernet A Andrews V Dormandy J: Increase in leg blood flow by normovolemic hemodilution in intermittend claudication Lancet 1979, ii: 166-172.
33. Anderson TJ Meredith IT Yeung AC Frei B Selwyn AP Ganz P: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion N Engl J Med 1995, 332: 488-493. Reducedincidence of coronary events associated with cholesterol-lowering therapy may be explained by the improvement of endothelium-dependent vasomotion and stabilization of atherosclerotic plaques.
34. Treasure CB Klein JL Weintraub WS Talley JD Stillabower ME Konsinski AS etal: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 1995, 332: 481-487.
35. Mittleman MA Maclure M Tofler GH Sherwood JB Goldberg RJ Muller JE: Triggering of acute myocardial infarction by heavy physical exertion -protection against triggering by regular exertion N Engl J Med 1993, 329: 1677-1683.
36. Willich SN Lewis M Löwel H Schubert F Schroder R: Physical exertion as a trigger of acute myocardial infarction N Engl J Med 1993, 329: 1684-1690.